Sector
PharmaceuticalsOpen
₹890Prev. Close
₹893.4Turnover(Lac.)
₹1.14Day's High
₹904.8Day's Low
₹84952 Week's High
₹1,19052 Week's Low
₹736Book Value
₹430.79Face Value
₹10Mkt Cap (₹ Cr.)
101.89P/E
25.82EPS
32.88Divi. Yield
0.4128 May 2024
12:00 AM
Dividend
Dividend Amount: 3.5
24 Jul 2024
12:00 AM
BookCloser
5 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
24 Jul 2024
12:00 AM
AGM
Announcement Date: 24 Jul, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 1.2 | 1.2 | 1.2 | 1.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 49.64 | 44.43 | 39.11 | 35.69 |
Net Worth | 50.84 | 45.63 | 40.31 | 36.89 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 68.6 | 57.26 | 51.86 | 48.02 |
yoy growth (%) | 19.78 | 10.41 | 7.99 | 1.07 |
Raw materials | -31.16 | -25.64 | -23.83 | -20.22 |
As % of sales | 45.43 | 44.77 | 45.94 | 42.11 |
Employee costs | -9.79 | -9.3 | -7.33 | -6.9 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 7.9 | 4.32 | 2.45 | 4.89 |
Depreciation | -1.92 | -1.86 | -1.47 | -1.28 |
Tax paid | -2.57 | -1.1 | -0.44 | -2.19 |
Working capital | 2.51 | 0.57 | 1.74 | 3.08 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 19.78 | 10.41 | 7.99 | 1.07 |
Op profit growth | 55.54 | 40.92 | -34.9 | 3.8 |
EBIT growth | 66.14 | 53.04 | -41.88 | -4.64 |
Net profit growth | 65.34 | 60.34 | -25.51 | -31.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,766.2 | 134.52 | 4,23,770.54 | 1,181.05 | 0.76 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,958.35 | 76.3 | 1,58,175.47 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,486.75 | 25.8 | 1,20,075.94 | 1,438.15 | 0.87 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,183 | 59.05 | 1,07,722.35 | 485 | 0.88 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,434.1 | 51.93 | 1,00,425.74 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Rajendra R Shah
Non Executive Director
Dilip R Shah
Independent Non Exe. Director
Bharat Dhirajlal Mehta
Non-Exec & Non-Independent Dir
Paresh Mistry
Non Executive Director
Janki Shah
Independent Director
Jayantilal D Raval
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Mercury Laboratories Ltd
Summary
Mercury Laboratories Limited, the registered partnership firm started its business activity in year 1962. Subsequently, the Company converted into Private Limited Company & incorporated in February, 1982. Later, it further converted into Limited Company in 1992 in Maharashtra. The Company is engaged in the business of Pharmaceutical items, medicinal drugs and formulations. It is a profit making and dividend paying public limited company.
Read More
What is the Mercury Laboratories Ltd share price today?
The Mercury Laboratories Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹849.05 today.
What is the Market Cap of Mercury Laboratories Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mercury Laboratories Ltd is ₹101.89 Cr. as of 08 May ‘25
What is the PE and PB ratio of Mercury Laboratories Ltd?
The PE and PB ratios of Mercury Laboratories Ltd is 25.82 and 1.97 as of 08 May ‘25
What is the 52 Week High and Low of Mercury Laboratories Ltd?
The 52-week high/low is the highest and lowest price at which a Mercury Laboratories Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Mercury Laboratories Ltd is ₹736 and ₹1190 as of 08 May ‘25
What is the CAGR of Mercury Laboratories Ltd?
Mercury Laboratories Ltd's CAGR for 5 Years at 22.39%, 3 Years at 19.27%, 1 Year at -1.73%, 6 Month at -13.27%, 3 Month at 1.39% and 1 Month at 7.47%.
What is the shareholding pattern of Mercury Laboratories Ltd?
The shareholding pattern of Mercury Laboratories Ltd is as follows:
Promoters - 73.66 %
Institutions - 0.00 %
Public - 26.34 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
